MARATTO

article · Research Journal of Pharmacy and Technology

The association between Covid-19 Infections, Severity, Complications and Vaccinations and Dyslipidemia in young age population - Clinical Pharmacy Approach

Abstract

Introduction: No studies determined the association between Covid – 19 infections and vaccination adverse reactions in the presence of dyslipidemia in young age population. Objectives: detecting the prevalence of dyslipidemia in young age population, initiating a dyslipidemia clinic in the British University in Egypt by pharmacy students and assess the association between Covid – 19 infections and vaccination adverse reactions in the presence of dyslipidemia. Methods: Dyslipidemia detection was done by pharmacy students. Two awareness campaigns were carried out to assess the background information of participants and a clinic was initiated to train students on dyslipidemia management. The association between Covid – 19 infections and vaccination adverse reactions in the presence of dyslipidemia in young age population was determined during patient’s follow up. Results: A total of 100 Students aged from 17 to 25 years old were enrolled in the study. Dyslipidemia risk factors were assessed, there was a statistically significant difference between males and females in lipid parameters. About 61% of participants showed at least one abnormal value in the lipid profile parameters. there was no statistically significant association between the presence of dyslipidemia by any mean and Covid – 19 infections, severity or complications in young age population. There was a statistically significant association between dyslipidemia and Covid – 19 vaccine adverse reactions in young age population. Conclusion: Pharmacy students can participate in facing Covid-19 pandemics that is sweeping the world. More studied are needed to explore the association between dyslipidemia and Covid – 19 vaccine adverse reactions in young age population.

Research topics

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Lipoproteins and Cardiovascular Health

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.52711/0974-360x.2023.00574

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.